QBiotics is solving major health issues for humans and companion animals. We discover, develop and commercialise novel pharmaceuticals based on plant-derived cell-signalling molecules sourced from the Australian tropical rainforest, and underpinned by our discovery platform EcoLogic™. We simultaneously develop our products for the human and veterinary markets, delivering early to market veterinary products as well as real world animal data that informs and de-risks early stages of our human programmes. We currently have two leading programmes. The first is an oncology drug, tigilanol tiglate, with activity against a range of solid tumours. Tigilanol tiglate is now registered as a veterinary pharmaceutical, brand name STELFONTA®, and is marketed in the US, EU, UK and Australia. The drug is also currently in human Phase II clinical development. Our second programme is a pharmaceutical, EBC-1013, that addresses all the requirements for healing chronic and acute wounds. We have a very skilled and enthusiastic team of 61 employees.
| Website | http://www.qbiotics.com |
| Revenue | $16 million |
| Employees | 30 (30 on RocketReach) |
| Founded | 2000 |
| Phone | +61 7 3870 8933 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Drug Discovery, Healthcare |
| Web Rank | 4 Million |
| Keywords | Pharmaceutical Development, Drug Discovery, Bioactive Molecules, Pharmaceutical Research, New Drug Development, Biotechnology, Drug Commercialization, Pharmaceutical Commercialization, Human Health, Animal Health, Plant Based Medicine, Innovative Medicines, Veterinary Pharmaceuticals, Therapeutic Solutions, Health Solutions |
| Competitors | AstraZeneca, Galapagos, CureVac, Novavax, Immunocore, Agenus, Iovance Biotherapeutics, Inc., Antengene, MediWound Ltd., OncoSec +41 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 54 Companies, NAICS Code 3254 Companies |
Looking for a particular QBiotics Group Limited employee's phone or email?
QBiotics Group Limited Questions
The QBiotics Group Limited annual revenue was $16 million in 2026.
Stephen Doyle is the CEO of QBiotics Group Limited.
30 people are employed at QBiotics Group Limited.
QBiotics Group Limited is based in Bowen Hills, Queensland.
The NAICS codes for QBiotics Group Limited are [325, 32, 541, 32541, 54, 3254].
The SIC codes for QBiotics Group Limited are [283, 28].
Top QBiotics Group Limited Employees
-
Victoria Gordon
CEO and Managing Director at QBiotics Group Limited
Brisbane, QLD, AU1 -
Peter Schmidt
Chief Operating Officer at QBiotics Group Limited
Brisbane City, QLD, AU1 -
Ahsan Syedali
Director CMC and Quality at QBiotics Group Limited
Melbourne, VIC, AU32 -
Ana Benatti
Head of Quality and Regulatory at QBiotics Group Limited
Brisbane City, QLD, AU2 -
Pamela Jones
Chief Veterinary Officer at QBiotics Group Limited
Houston, Texas, United States23 -
Katrina Pirlo
Clinical Project Manager at QBiotics Group Limited
Brisbane, QLD, AU1 -
Daniel Swart
Head of Human Clinical Operations at QBiotics Group Limited
Sunshine Coast, QLD, AU1
